Sy, Eduardo C.
HRN: 21-46-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/26/2022
07/03/2022
IV
2.25gm
Q8
CBC
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose